# Survivin Urine mRNA Assay Risk of Bladder Cancer Study

> **NCT00315653** · — · COMPLETED · sponsor: **Fujirebio Diagnostics, Inc.** · enrollment: 600 (—)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00315653
- **Lead sponsor:** Fujirebio Diagnostics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 600 (—)
- **Last updated:** 2008-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315653, "Survivin Urine mRNA Assay Risk of Bladder Cancer Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00315653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*